Riskpilot← Back to searchSign inGet full accessHelsingborgs Vaccinationsbyrå AB
ABActiveOrg 5565838074Karl Johans Gata 10General medical practice activities · NACE 8621Est. 20001 employees
Revenue 2025
SEK 878K
+457% vs 2024
EBITDA margin
-3.3%
-128% vs 2024
Equity ratio
39.4%
Financial strength
Net profit 2025
SEK -35K
-144% vs 2024
| Revenue | SEK 878K | +457% |
| EBITDA | SEK -29K | -128% |
| Net profit | SEK -35K | -144% |
| Total assets | SEK 453K | -9% |
| Equity | SEK 178K | -63% |
| Employees | 1 | — |
Legal name
Helsingborgs Vaccinationsbyrå AB
Org number
5565838074
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 februari 2000
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet som vaccinationsbyrå, inklusive rådgivning och administrering av vaccin för förebyggande vård och resor. Verksamheten omfattar även köp och försäljning av vaccin samt därmed förenlig verksamhet. Bolaget ska även bedriva handel med och förvaltning av aktier, andra värdepapper och fast egendom, samt därmed förenlig verksamhet.
Address
Karl Johans Gata 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 216 | 216 | 234 | 157 | 878 |
| Staff expenses | — | — | — | — | −213 |
| EBITDA | 172 | 140 | 179 | 106 | −29 |
| Depreciation & amort. | −0 | −1 | −6 | −6 | −6 |
| EBIT | 172 | 139 | 173 | 100 | −35 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | 172 | 139 | 173 | 100 | −35 |
| Tax | −37 | −29 | −36 | −21 | — |
| Net profit | 135 | 110 | 137 | 80 | −35 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 286 | 387 | 435 | 497 | 453 |
| Equity | 255 | 366 | 403 | 483 | 178 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 31 | 21 | 32 | 14 | 275 |
| Total debt | 31 | 21 | 32 | 14 | 275 |
EBITDA margin
-3.3%
This company
15.8%
Market median
-121% vs market
20212025
Equity ratio
39.4%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
-19.5%
This company
18.4%
Market median
-206% vs market
20212025
Net profit margin
-4.0%
This company
8.1%
Market median
-149% vs market
20212025
Asset turnover
1.94×
This company
1.12×
Market median
+73% vs market
20212025
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Helsingborgs Vaccinationsbyrå AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Gunnar Michael Seipel | Board of Directors | 0 companies |
| Eva Helene Seipel | Board of Directors | 0 companies |
| Clarence Carl Michael Seipel | Deputy Board Member | 0 companies |